Abstract
Introduction
The BK virus nephropathy (BKVN) is one of the most important infectious complications in renal transplant recipients. As BKVN lacks any effective antiviral treatment, early diagnosis is required in order to try to limit viral replication and subsequent damage to the renal allograft, by reducing the immunosuppressive therapy. Our study, the first of its kind in Romania, aimed to assess the prevalence of BKVN among renal transplant patients in our center.
Materials and methods
In this cross-sectional study, we included 143 renal transplant patients from our center who had received their renal allograft between 2005 and 2010. We searched for latent BK virus infection by detection of serum anti-BK virus antibodies, using an in-house developed enzyme-linked immunosorbent assay (ELISA) technique. Serology was considered positive if results were >0.33 optical density units. In patients with positive serology, we searched for BKVN with qualitative (polymerase chain reaction, PCR) and quantitative (TaqMan real-time PCR) molecular techniques. Additionally, we searched for other viral infections, including hepatitis B (with HBsAg test), hepatitis C (with anti-HCV Abs test), and cytomegalovirus (CMV, with pp65Ag test).
Results
All patients screened with ELISA were found to have positive BK virus serology and two of these were diagnosed with BKVN. Both patients with BKVN presented with acute impairment of the renal graft function, and one of them also developed a ureteral graft stenosis. In both cases, BKVN resolved after reduction of immunosuppressive doses. We also diagnosed hepatitis B in 18.18%, hepatitis C in 7.0%, and CMV in 27.97% of patients.
Conclusions
Our study demonstrates for the first time the existence of BK virus in Romania, and we believe it opens the prospective of diagnosing BKVN in high-risk patients in our country in the future. In renal transplant patients from our center, we found the prevalence of BK virus infection to be as high as 100%. The prevalence of hepatitis B and CMV was also remarkably high. In patients with BKVN, the reduction of immunosuppression enables the spontaneous resolution of the disease.
Similar content being viewed by others
References
Mackenzie EF, Poulding JM, Harrison PR et al (1978) Human polyoma virus (HPV)—a significant pathogen in renal transplantation? Proc Eur Dial Transplant Assoc 15:352–360
Mannon RB (2004) Polyomavirus nephropathy: what have we learned? Transplantation 77:1013–1018
Binet I, Nickeleit V, Hirsch HH et al (1999) Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67:918–922
Bohl DL, Storch GA, Ryschkewitsch C et al (1999) Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 5:2213–2221
Prince O, Savic S, Dickenmann M, Steiger J, Bubendorf L, Mihatsch M (2009) Risk factors for polyomavirus nephropathy. Nephrol Dial Transplant 24(3):1024–1033
Mengel M, Marwedel M, Radermacher J et al (2003) Incidence of polyomavirus-nephropathy in renal allograft: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 18:1190–1196
Brennan DC, Agha I, Bohl DL et al (2005) Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5:582–594
Beimler J, Sommerer C, Zeier M (2007) The influence of immunosuppression on the development of BK virus nephropathy—does it matter? Nephrol Dial Transplant 22(Suppl 8):66–71
Medeiros M, Alberú J, García R, Fuentes Y, Velasquez L (2008) Polyoma virus in transplant recipients. Nefrología 28(2):203–211
Xiaoli L, Doucette K, LeBlanc B, Cockfield S, Preiksaitis JK (2007) Monitoring of polyomavirus BK viruria and viremia in renal allograft recipients by use of a quantitative real time PCR assay: one year prospective study. J Clin Microbiol 45(11):3568–3573. doi:10.1128/JCM.00655-07
Randhawa P, Ho A, Shapiro R, Vats A, Swalsky P, Finkelstein S, Uhrmacher J, Weck K (2004) Correlates of quantitative measurement of BK polyomavirus DNA with clinical course of BKV infections in renal transplant patients. J Clin Microbiol 42(3):1176–1180. doi:10.1128/JCM.42.3.1176-1180.2004
Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH (2000) Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 342:1309–1315
Hayran M, Ustaçelebi S (1991) New human polyomavirus: BK virus antibody levels in different age groups using the hemagglutination inhibition test. Mikrobiyoloji Bull 25(2):173–177
Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199(6):837–846
Hirsch HH, Steiger J (2003) Polyomavirus BK. Lancet Infect Dis 3(10):611–623
Nickeleit V, Hirsch HH, Zeiler M et al (2000) BK virus nephropathy in renal transplants—tubular necrosis, MHC class II expression and rejection in a puzzling game. Nephro Dial Transplant 15:324–332
Kahan AV, Coleman DV, Koss LG (1980) Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol 74(3):326–332
Drachenberg CB, Beskow CO, Cangro CB et al (1999) Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol 30(8):970–977
Fernando AB, Staras AS, Dollard S, Cannon MJ (2007) Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 7:71. doi:10.1186/1471-2334-7-71
Toupance O, Bouedjoro-Camus MC, Carquin J et al (2000) Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses. Transpl Int 13:413–419
Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002) The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2(9):850–856
Reischig T, Jindra P, Svecova M et al (2006) The impact of CMV disease and asymptomatic infection on acute renal allograft rejection. J Clin Virol 36:146–151
Acknowledgments
This study was funded by a research grant from the University of Medicine and Pharmacy “Gr. T. Popa”, Iasi, and by the National Transplantation Agency of Romania.
We would like to thank Professor Ugo Moens from the University of Trømso, Norway, for providing us with positive controls and with primers for the nested PCR, as well as for his precious guidance. We would also like to thank Dr. Aurelija Zvirbliene from the Institute of Biotechnology in Vilnius, Lithuania, for providing us with positive controls, antigens, and guidance for the EIA method.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Enache, E.M., Iancu, L.S., Hogas, S. et al. Screening for latent BK virus infection in a renal transplant population for the first time in Romania: a single-center experience. Int Urol Nephrol 44, 619–623 (2012). https://doi.org/10.1007/s11255-011-9954-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-011-9954-5